|Bid||0.00 x 800|
|Ask||0.00 x 1400|
|Day's range||126.44 - 129.42|
|52-week range||82.22 - 147.54|
|Beta (5Y monthly)||1.09|
|PE ratio (TTM)||36.05|
|Earnings date||20 Mar 2023 - 24 Mar 2023|
|Forward dividend & yield||1.36 (1.05%)|
|Ex-dividend date||02 Dec 2022|
|1y target est||128.50|
The average brokerage recommendation (ABR) for Nike (NKE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Simeon Siegel, BMO Managing Director, discusses Peloton's business and reports of its possible sale to another company. You can see the full interview here. Key video highlights 00:34 On companies that shouldn't buy Peloton 01:06 On Apple's position to buy 01:33 On Peloton's brand
BMO Managing Director Simeon Siegel breaks down Peloton's stock surge following a revenue beat, the upwards trends the luxury fitness brand is riding after a tough 2022, and comments on Nike's sneaker collaboration with jeweler Tiffany & Co.